WEE1 Kinase Inhibitor AZD1775 Has Preclinical Efficacy in LKB1-Deficient Non–Small Cell Lung Cancer
Cancer Research - United States
doi 10.1158/0008-5472.can-16-3565
Full Text
Open PDFAbstract
Available in full text
Date
June 26, 2017
Authors
Publisher
American Association for Cancer Research (AACR)